Federal Expert Group recommends that men between the ages of 55 and 69 years be screened for prostate cancer. The recommendations, published on Tuesday by the task force on preventive services in the United States, evaluated the benefits of screening men for prostate cancer. According to the group, analysis of prostate-specific antigen (PSA) should be offered on the basis of professional judgment and the patient's preferences. According to a major study on the PSA test could save lives when used to screen men aged 50-60 years.
European clinical study found that periodic analyzes prevent seven deaths per 10,000 men screened.
In 2012, 90 percent of men, in whom the diagnosis was confirmed by biopsy, immediately began a course of radiation therapyor taking a decision on surgery, despite the growing evidence that many of these cancers will never become dangerous. Now, no more than 60 percent of these men begin treatment immediately. Others begin the process of "active surveillance," in which surgery or radiation are used only if the cancer progresses. Meanwhile, urologists use genetic analysis, targeted biopsy procedure and improved imaging methods to identify more aggressive prostate tumors which require quick action.
Despite efforts to improve the treatment of prostate cancer, Radiation therapy, and surgery still affect patients: two-thirds of men experience long-term erectile dysfunction or urinary incontinence. But as more and more men, first observe the tumor, they are less exposed to the negative effects of the treatment.
In the United States, the risk of prostate cancer is 13 percent, and the risk of mortality from the disease - only 2.5 percent. Without screening, many men do not even know about the disease, which can grow slowly over many years.
According to studies, African Americans nearly twice as likely to die from prostate cancer than men Eurasian race. Family history of prostate cancer and cancers called adenocarcinomas (which includebreast cancer , Ovarian, pancreatic and colorectal cancer) can also be a cause regular screening.
Some men are skeptical about the screening. Some cancer ill someone from relatives, while others are so many health problems that such a long-term threat, as prostate cancer, does not seem so important. Today, personalized medicine and joint decision-making to the fore. Patients are too different, and a single type of treatment does not fit all.
Recommendations of new target groups comply with the recommendations of the American Urological Association, which indicated that men aged 55 to 69 years of age should be informed about the benefits of screening.